Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10